Award recordCONTRACT

EXELAN PHARMACEUTICALS INC

PIID 36C25926F0100· VHA· NETWORK CONTRACT OFFICE 19 (36C259)· 3650 · CHEMICAL AND PHARMACEUTICAL PRODUCTS MANUFACTURING MACHINERY· FY2026· $587,007 net obligations· UEI FYZXNHSQTMG8· FL

Description

EMERGENCY PHARMACY LENALIDOMIDE FOR PATIENT TREATMENT

First action · last action
2026-02-05 · 2026-08-14
Transactions
3
First transaction's obligation
$587,007
Base + all options value (sum of deltas)
$587,007
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
36F79720D0227
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 3 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$587,007$0Base award · 2026-02-05 · this action $587,007 · running total $587,007Modification P00001 · 2026-02-05 · this action $0 · running total $587,007Modification P00002 · 2026-08-14 · this action -$0 · running total $587,007
  • Base2026-02-05+$587,007= $587,007
  • Mod P000012026-02-05+$0= $587,007
  • Mod P000022026-08-14-$0= $587,007
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2026-02-05+$587,007$587,007EMERGENCY PHARMACY LENALIDOMIDE FOR PATIENT TREATMENT
Mod P00001· OTHER ADMINISTRATIVE ACTION2026-02-05+$0$587,007EMERGENCY PHARMACY LENALIDOMIDE FOR PATIENT TREATMENT
Mod P00002· FUNDING ONLY ACTION2026-08-14−$0$587,007EMERGENCY PHARMACY LENALIDOMIDE FOR PATIENT TREATMENT

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI FYZXNHSQTMG8)

AwardOffice · PSC / listingNet obligationsFY
36C24226N0564242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS$5,337,256FY2026
36C25926F0197NETWORK CONTRACT OFFICE 19 (36C259) · 6505 · DRUGS AND BIOLOGICALS$1,844,059FY2026
36C26026F0261260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$918,831FY2026
36E79726D0021NAC PHARMACEUTICALS (36E797) · 6505 · DRUGS AND BIOLOGICALS$0FY2026
36C26026F0169260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$712,808FY2026
36C24426N0400244-NETWORK CONTRACT OFFICE 4 (36C244) · 6505 · DRUGS AND BIOLOGICALS$1,487,248FY2026

Other recipients under 3650 from NETWORK CONTRACT OFFICE 19 (36C259) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C25926F0127COSETTE PHARMACEUTICALS, INC.NETWORK CONTRACT OFFICE 19 (36C259)$3,466FY2026
36C25926F0121NEUROTECH PHARMACEUTICALS, INCNETWORK CONTRACT OFFICE 19 (36C259)$187,506FY2026
36C25926F0087COSETTE PHARMACEUTICALS, INC.NETWORK CONTRACT OFFICE 19 (36C259)$3,466FY2026
36C25926F0063SEQIRUS USA INCNETWORK CONTRACT OFFICE 19 (36C259)$33,260FY2026
36C25923P1204TRILLAMED LLCNETWORK CONTRACT OFFICE 19 (36C259)$100,644FY2023

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C25926F0100_3600_36F79720D0227_3600 · retrieved 2026-09-26.